Compounds > medroxyprogesterone acetate
Page last updated: 2024-08-17

medroxyprogesterone acetate and Drug Withdrawal Symptoms

medroxyprogesterone acetate has been researched along with Drug Withdrawal Symptoms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barad, DH; Barnabei, VM; Brzyski, RG; Cochrane, BB; Gass, M; Hays, J; Lane, DS; Larson, JC; Manson, JE; Ockene, JK; Rosal, MC; Wassertheil-Smoller, S; Wylie-Rosett, J1
Petitti, DB1
Flowers, CE; Hyde, BM; Wilborn, WH1
Anttila, L; Erkkola, R; Irjala, K; Kaihola, HL; Koskinen, P; Ruutiainen, K1

Other Studies

4 other study(ies) available for medroxyprogesterone acetate and Drug Withdrawal Symptoms

ArticleYear
Symptom experience after discontinuing use of estrogen plus progestin.
    JAMA, 2005, Jul-13, Volume: 294, Issue:2

    Topics: Aged; Anxiety; Cross-Sectional Studies; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Logistic Models; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pain; Progestins; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Vasomotor System

2005
Some surprises, some answers, and more questions about hormone therapy: further findings from the Women's Health Initiative.
    JAMA, 2005, Jul-13, Volume: 294, Issue:2

    Topics: Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Progestins; Substance Withdrawal Syndrome

2005
Mechanisms of uterine bleeding in postmenopausal patients receiving estrogen alone or with a progestin.
    Obstetrics and gynecology, 1983, Volume: 61, Issue:2

    Topics: Adult; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Histocytochemistry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Microscopy, Electron; Middle Aged; Norethindrone; Norethindrone Acetate; Substance Withdrawal Syndrome; Uterine Hemorrhage

1983
Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovaries.
    Fertility and sterility, 1992, Volume: 58, Issue:4

    Topics: Adolescent; Adult; Androgens; Female; Gonadotropins, Pituitary; Humans; Medroxyprogesterone Acetate; Oligomenorrhea; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Substance Withdrawal Syndrome; Uterine Hemorrhage

1992